The Families At Risk for Interstitial Lung Disease Study
FAR-ILD: The Families At Risk for Interstitial Lung Disease Study
Sponsor: NIH
Enrolling: Male and Female Patients
Study Length: 1 Days
Clinic Visits: 1
IRB Number: AAAR1916
U.S. Govt. ID: NCT03641742
Contact: M. Atif Choudhury: 212-342-4551 /
Additional Study Information: The Families At-Risk for Interstitial Lung Disease (FAR-ILD) study is designed to detect and study the earliest stages of ILD in adults with a family history of ILD. FAR-ILD is a non-interventional study. This means that FAR-ILD is not involved in testing any new interventions or therapies. The purpose of FAR-ILD is to gather data on family members of patients with pulmonary fibrosis over a long period of time in order to help physicians and investigators better understand interstitial lung disease. There is no cost associated with participating in FAR-ILD and your insurance will not be billed. All study procedures are paid for in full by the National Institutes of Health. If you enroll in the FAR-ILD study, you may be asked to undergo the following study-related procedures: CAT scan, pulmonary function testing, blood draw from a vein, bronchoscopy, & return visits.
This study is closed
Christine Kim Garcia, MD
Do You Qualify?
Do you or one of your family members have interstitial lung disease or pulmonary fibrosis? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
M. Atif Choudhury